Navigation Links
EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
Date:10/24/2007

Results Demonstrate Activity in Advanced Disease

ROCKVILLE, Md., Oct. 24 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of results for its Phase 2, open-label study for Panzem(R) NCD (2ME2 or 2-methoxyestradiol) in patients with ovarian cancer. The results were presented by Dr. Daniela Matei, principal investigator for the study representing the Hoosier Oncology Group, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held this week in San Francisco, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Data from the Phase 2 study demonstrate that Panzem(R) NCD, administered as a single agent in patients with platinum refractory epithelial ovarian cancer, resulted in one patient with a confirmed partial response of their CA- 125. Five patients, out of the 18 patients enrolled, achieved stable disease lasting greater than three months. Panzem(R) NCD was well tolerated and no significant neuropathy, myelosuppression or thromboembolic side effects were reported. Three patients remained on study for more than 6 months and two of these patients are still on study.

Data from in vitro studies demonstrated that 2ME2 has activity against a variety of ovarian carcinoma cell lines including those resistant to other chemotherapeutic agents. In preclinical models of ovarian cancer, 2ME2 has shown a significant survival advantage compared to animals that did not receive treatment. Furthermo
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Experimental treatment for Ebola Virus Shows promising results in mice
8. Hormone Deficiency Results In Miscarriage
9. Gleevec gets hopeful results
10. Breast Implants May Interfere With The Interpretation Of Mammogram Results
11. DNA Testing For More Accurate Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... The North American air and missile defense ... and is expected to register a CAGR of 8.22% to ... biggest market for the air and missile defense radar system. ... witnessed budget cuts as well. , Browse through the TOC ... report, to get an idea of the in-depth analysis provided. ...
(Date:7/24/2014)... -- Even though its use is often advised by doctors, ... not help treat lower back pain, according to a new ... no more effective than a dummy pill for more than ... showing no effect in easing discomfort, the study also found ... to back pain, nor did it improve patients, overall quality ...
(Date:7/24/2014)... emergency departments can be reduced by enabling patients to ... doctor,s surgery. This is just one of several recommendations ... at the University of Bristol. , Called ,Primary care ... reviews, the report has been compiled by researchers from ... at evidence from studies around the world. They found ...
(Date:7/24/2014)... have identified two previously undescribed radiological signs ... gastric bands. Adding widespread knowledge of the ... margin by more than 2.4 cm from ... air-fluid,level above the band on a frontal ... in diagnosing affected bariatric patients. These signs ...
(Date:7/24/2014)... neonicotinoids, were found commonly in streams throughout the ... is the first broad-scale investigation of neonicotinoid insecticides ... the first conducted within the United States. , ... pests, use of neonicotinoid insecticides has dramatically increased ... particularly in the Midwest. The use of ...
Breaking Medicine News(10 mins):Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 2Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 4Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 2Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 3Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:Corn & soy insecticides similar to nicotine found widespread in Midwest rivers -- USGS news 2
... a twin are at upto 5 times higher risk of suffering ... was conducted on over 800 pairs of twins in the UK ... age of 40 was 3-5 times higher in twins than women ... ten years or earlier than the usual period. Only 1-in-100 women ...
... The diagnosis of Kylie Minogue with breast cancer has led to ... get breast cancer//. ,Cancer Research UK said that ... strike the under-70s than women over 70,. ,Their survey ... that a woman's risk of breast cancer was increased if she ...
... toddlers, reports a major study conducted on the side effects of ... proposed immunization for all kids of the age 6 months to ... sharp rise in the number of children getting vaccinated. This proposal ... years as often as the old people. ,This study ...
... A 1-year-old girl has been diagnosed with polio in spite ... an official statement, polio can be prevented by 4-10 doses ... this girl called Jannat. ,“Earlier she used to ... Jannat's Mother, Akhbari Khatun says.,Jannat was diagnosed with polio just ...
... from heart surgery. A Researcher from the University of Calary has ... Kathryn King, in her research informs that those who wore ... and discomfort, when compared those who were in a ... to the Canadian Cardiovascular Congress in Vancouver after two years of ...
... A recent research proposes that radiations from handsets may affect fertility ... count than normal.// ,A study conducted on 361 ... the daily mobile use by the man, there was a decrease ... a 40% reduction in sperm count in men who used mobile ...
Cached Medicine News:Health News:Mobile use increases risk of infertility in men 2
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
(Date:7/24/2014)... July 24, 2014  Bayer HealthCare today announced ... evaluated a 15% foam formulation of its compound ... inflammatory papules and pustules of rosacea. An AzA ... complement the currently available AzA gel formulation. Papulopustular ... (papules and pustules) as well as erythema (redness) ...
(Date:7/24/2014)... , July 24, 2014  Market Diagnostics ... IVD Insights™ LabFile , a data resource ... US clinical laboratory universe and identifying target In ... a proprietary database that provides IVD manufacturers with ... tests, relying on clear and consistent definitions of ...
Breaking Medicine Technology:Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 3MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2
... June 18, 2007 /PRNewswire/ -- Today, results,from ... comparing two angiotensin,receptor blockers (ARBs) in hypertensive ... 17th annual European Meeting on,Hypertension in Milan, ... parallel group,multicenter study included 860 hypertensive patients,(>130/80mmHg) ...
... 2007 --- Millipore Corporation today announced the release ... lines. The,research was conducted by the Department ... plc, whose ReNcell,distribution agreement with Millipore was announced ... Dr. Vi Chu, research &,development scientist for Millipore’s ...
Cached Medicine Technology:New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 2New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 3New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 4Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish....
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment....
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades....
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare....
Medicine Products: